Total 1Q 2025 net product revenue of $121.5 million, representing 62% year-over-year growth
Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Seeking Alpha / 9 hours ago 1 Views
Seeking Alpha / 9 hours ago 1 Views
Total 1Q 2025 net product revenue of $121.5 million, representing 62% year-over-year growth
Comments